Bellevue Group Ag Ironwood Pharmaceuticals Inc Transaction History

Bellevue Group Ag

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$8.27 - $12.73 $632,655 - $973,845	-76,500 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$7.8 - $16.13 $22,620 - $46,777	-2,900 Reduced 3.65%	76,500 $793,000
Q3 2018 Nov 13, 2018	BUY	$14.31 - $17.65 $1.14 Million - $1.4 Million	79,400 New	79,400 $1.47 Million

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $539M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

Stay updated on Bellevue Group Ag with notifications on news.